Skip to main content

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

restor3d, a Duke startup, raises $13M from 101 investors, merges with Pennsylvania medtech firm

DURHAM, May 28, 2021 (WRAL TechWire) – The 3D printed implant company restor3d, based in Durham, announced a merger with Kinos Medical earlier this month, and has also now raised $13 million in equity funding from…

Read More

TruDiagnostic Signed an Exclusive License Agreement with Duke University to use the DunedinPoAm Rate of Aging Algorithm

Lexington, KY & Durham, NC – TruDiagnostic signed the exclusive license agreement to the DunedinPoAm pace of aging methylation prediction algorithm. Pace of Aging is how quickly a person’s epigenetic markers are changing to hasten…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/Tellus-Logo-1.png

Tellus Therapeutics Secures Seed Financing to Develop the First Treatment for Newborns with White Matter Brain Injury

– Collaboration with Xontogeny provides funding and key advisory support for early development – DURHAM, N.C.–(BUSINESS WIRE), May 12, 2021–Tellus Therapeutics, Inc., a biopharmaceutical company developing TT-20 as a treatment for white matter injury (WMI)…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/Virus-image-for-Coronavirus-story-1.jpg

New Vaccine Blocks COVID-19 and Variants, Plus Other Coronaviruses

Study in animals identifies a potential way to build vaccines to fight future pandemics By Sarah Avery A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/HiggsBoson@3x-1-1.png

Medtronic Announces CareGuidePro™, a New Mobile App and Online Platform for Patients to Navigate Their Spinal Cord Stimulation Journey

New App Developed in Partnership with Higgs Boson Health, a Physician-Led Digital Health and Patient Engagement Solutions Provider “Knowledge is power, and digital health solutions like CareGuidePro give patients the tools they need to ask…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/isolere-logo-1.png

Isolere Bio Closes $7 Million in Seed Funding

Biomanufacturing innovations to accelerate the development and commercialization of cell and gene therapies   “We are thrilled to be teaming up with a top-tier, science-driven investor who believes in and shares our mission of delivering…

Read More

DJO® Acquires MedShape, Inc.

Businesswire, April 26, 2021 Acquisition expands foot and ankle business and adds innovative shape memory technologies DJO, a subsidiary of Colfax Corporation (NYSE: CFX) and a leading global provider of medical technologies to get and…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/logo-300x63-1.png

StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies

– StrideBio receives exclusive license to novel cross-species evolved AAV vectors and an enzymatic approach for neutralizing antibody evasion – – Master Sponsored Research Agreement will support collaborative research and development of multiple novel gene…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2022/08/Tavros-Therapeutics-Logo-1.png

Raleigh investor bets $1.8M on Duke spin-out

By Lauren Ohnesorge  –  Senior Staff Writer, Triangle Business Journal a day ago Another day, another million for a Triangle investor. This time it’s Raleigh’s Piedmont Capital Investments, raising millions earmarked for local biotech innovation. The latest fund,…

Read More